You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A. for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in Italy

News provided by

Orexigen Therapeutics, Inc.

Mar 27, 2017, 18:03 ET